JAK/STAT signaling in hepatocellular carcinoma

JJ Hin Tang, DK Hao Thng, JJ Lim, TB Toh - Hepatic oncology, 2020 - Taylor & Francis
Liver cancer is the second most lethal cancer in the world with limited treatment options.
Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has …

[HTML][HTML] Mitochondria-meditated pathways of organ failure upon inflammation

AV Kozlov, JR Lancaster Jr, AT Meszaros, A Weidinger - Redox biology, 2017 - Elsevier
Liver failure induced by systemic inflammatory response (SIRS) is often associated with
mitochondrial dysfunction but the mechanism linking SIRS and mitochondria-mediated liver …

Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and …

EO List, DE Berryman, K Funk, A Jara, B Kelder… - …, 2014 - academic.oup.com
GH is an important regulator of body growth and composition as well as numerous other
metabolic processes. In particular, liver plays a key role in the GH/IGF-I axis, because the …

[HTML][HTML] Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids

H Lu - Acta Pharmaceutica Sinica B, 2016 - Elsevier
The liver is essential for survival due to its critical role in the regulation of metabolic
homeostasis. Metabolism of xenobiotics, such as environmental chemicals and drugs by the …

Non-pituitary GH regulation of the tissue microenvironment

V Chesnokova, S Melmed - Endocrine-related cancer, 2023 - erc.bioscientifica.com
Non-pituitary growth hormone (npGH) expression is well established in extrapituitary
tissues, but an understanding of the physiological role of npGH remains rather limited. Pro …

Cytokines and STATs in liver fibrosis

X Kong, N Horiguchi, M Mori, B Gao - Frontiers in physiology, 2012 - frontiersin.org
Liver fibrosis, or cirrhosis, is a common end-stage condition of many chronic liver diseases
after incomplete recovery from hepatocyte damage. During fibrosis progression …

[HTML][HTML] Hepatic growth hormone-JAK2-STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression

D Kaltenecker, M Themanns, KM Mueller, K Spirk… - Cytokine, 2019 - Elsevier
The rising prevalence of obesity came along with an increase in associated metabolic
disorders in Western countries. Non-alcoholic fatty liver disease (NAFLD) represents the …

mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma

T Li, J Weng, Y Zhang, K Liang, G Fu, Y Li, X Bai… - Cell death & …, 2019 - nature.com
Hepatocellular carcinoma (HCC) can be the last step of nonalcoholic fatty liver disease
(NAFLD) evolution, and the main characteristic of NAFLD is alteration in lipid metabolism …

[HTML][HTML] STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease

M Fragiadaki, M Lannoy, M Themanns, B Maurer… - Kidney international, 2017 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) leads to renal failure. The hallmark
of ADPKD is increased epithelial proliferation, which has been proposed to be due to …

[HTML][HTML] Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular …

MAA El-Makarem, MF Kamel, AA Mohamed, HA Ali… - Plos one, 2022 - ncbi.nlm.nih.gov
Results Compared with cirrhotic patients without HCC and healthy controls, cirrhotic patients
with HCC had significantly lower hepatic expression of GHR, STAT5, and IGF-1proteins …